Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Topadur Pharma AG currently has 1 pending office action in its patent portfolio. This action is assigned to a distinct examiner, SHTERENGARTS, SAMANTHA L. As the busiest examiner for the company, SHTERENGARTS, SAMANTHA L is responsible for 1 pending office action. The current prosecution data shows a relationship between the company's total pending actions and the individual examiner. This structure indicates that the company's active patent acquisition is focused on this review process.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHTERENGARTS, SAMANTHA L | 1 | 79.5% | +8.0% |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18841618 | TOPICAL COMPOSITIONS AND USES THEROF | SHTERENGARTS, SAMANTHA L | — | §103§112DP | Non-Final OA | — | Pending | Aug 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial